Ruxience Interactions
There are 192 drugs known to interact with Ruxience (rituximab), along with 7 disease interactions. Of the total drug interactions, 53 are major, 134 are moderate, and 5 are minor.
- View all 192 medications that may interact with Ruxience
- View Ruxience disease interactions (7)
Most frequently checked interactions
View interaction reports for Ruxience (rituximab) and the medicines listed below.
- albuterol
- Arava (leflunomide)
- aspirin
- azelastine nasal
- baclofen
- Benadryl (diphenhydramine)
- benzonatate
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- calcium citrate
- CellCept (mycophenolate mofetil)
- cyclobenzaprine
- Cymbalta (duloxetine)
- dicyclomine
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone
- folic acid
- gabapentin
- hydroxychloroquine
- Imuran (azathioprine)
- magnesium oxide
- methotrexate
- mycophenolate mofetil
- Plaquenil (hydroxychloroquine)
- prednisone
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Ruxience disease interactions
There are 7 disease interactions with Ruxience (rituximab) which include:
- autoimmune diseases
- cardiac dysfunction
- hepatitis B
- TLS
- bone marrow suppression
- infections
- renal impairment
Report options
More about Ruxience (rituximab)
- Ruxience consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Vincristine
Vincristine systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.